Electrochemiluminescence Lateral Flow Immunoassay Using Ruthenium(II) Complex-Loaded Dendritic Mesoporous Silica Nanospheres for Highly Sensitive and Quantitative Detection of SARS-CoV-2 Nucleocapsid Protein

被引:5
|
作者
Fu, Wenxuan [1 ]
Wang, Xuexue [2 ]
Ying, Xudong [1 ]
Sun, Tao [3 ]
Wang, Yafeng [4 ]
Wang, Jing [2 ]
Su, Bin [1 ]
机构
[1] Zhejiang Univ, Inst Analyt Chem, Dept Chem, Hangzhou 310058, Peoples R China
[2] Zhejiang Univ Technol, Coll Chem Engn, Hangzhou 310014, Peoples R China
[3] Zhejiang Univ, Afiliated Hosp 2, Sch Med, Dept Lab Med, Hangzhou 310019, Peoples R China
[4] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Clin Lab, Hangzhou 310016, Peoples R China
基金
中国国家自然科学基金;
关键词
dendritic mesoporous silica nanospheres; electrochemiluminescence; lateral flow immunoassay; paper electrode; SARS-CoV-2; ELECTROGENERATED CHEMILUMINESCENCE; NANOPARTICLES; SERS;
D O I
10.1002/adfm.202409632
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Lateral flow immunoassays (LFIA) are widely used for the cost-effective and rapid detection of diverse analytes. However, traditional LFIA suffers from difficulties in providing quantitative results and has low sensitivity. Herein, LFIA is combined with electrochemiluminescence (ECL), a leading transduction technique with high sensitivity and wide dynamic range, to achieve highly sensitive and quantitative detection of severe acute respiratory syndrome coronavirus nucleocapsid protein (SARS-CoV-2 N protein). Ruthenium(II)-based complexes are synthesized and loaded into dendritic mesoporous silica nanospheres (PEI-Ru/dSiO2), which possessed central-radial pore channels and served as tags for ECL-LFIA. The electrodes are fabricated on a nitrocellulose (NC) membrane, which simplifies the structure of the ECL-LFIA. PEI-Ru/dSiO2 is captured on the electrode surface via a sandwich immunoreaction, which enhances the ECL signal by decreasing the distance between PEI-Ru/dSiO2 and the electrode surface. Using 2,2-bis(hydroxymethyl)-2,2 ',2 ''-nitrilotriethanol (BIS-TRIS) as coreactant, the ECL-LFIA is used for detecting SARS-CoV-2 N protein, with a linear range of 1-104 ng mL-1 and a limit of detection (LOD) of 0.52 ng mL-1. ECL-LFIA can also be used to detect analytes in complex matrices. These results demonstrate that the prepared ECL-LFIA has great potential as a point-of-care testing platform for the rapid and quantitative detection of disease biomarkers. Electrochemiluminescence lateral flow immunoassay (ECL-LFIA) strips are prepared by fabricating three electrodes on a nitrocellulose membrane, which simplifies electrode fixation and reduces the distance between the ECL luminophore and electrode surface, promoting ECL reactions. Using ruthenium(II) complex-loaded dendritic mesoporous silica nanospheres as tags (PEI-Ru/dSiO2), the ECL-LFIA strip enables the rapid and quantitative detection of disease biomarkers. image
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Clinical performance of SARS-CoV-2 antigen-detection rapid diagnostic test using SERS-based lateral flow immunoassay
    Yoon, Sumi
    Lim, Yong Kwan
    Kweon, Oh Joo
    Kim, Tae-Hyoung
    Lee, Mi-Kyung
    HELIYON, 2023, 9 (09)
  • [32] Development and validation of a rapid and easy-to-perform point-of-care lateral flow immunoassay (LFIA) for the detection of SARS-CoV-2 spike protein
    Mohammad, Shamim
    Wang, Yuxia
    Cordero, John
    Watson, Christopher
    Molestina, Robert
    Rashid, Sujatha
    Bradford, Rebecca
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay
    Chen, Zhenhua
    Zhang, Zhigao
    Zhai, Xiangming
    Li, Yongyin
    Lin, Li
    Zhao, Hui
    Bian, Lun
    Li, Peng
    Yu, Lei
    Wu, Yingsong
    Lin, Guanfeng
    ANALYTICAL CHEMISTRY, 2020, 92 (10) : 7226 - 7231
  • [34] Rapid detection of SARS-CoV-2 RNA using a one-step fast multiplex RT-PCR coupled to lateral flow immunoassay
    Ali, Insaf Bel Hadj
    Souguir, Hejer
    Melliti, Mouna
    Mohamed, Mohamed Vall Taleb
    Ardhaoui, Monia
    Ayouni, Kaouther
    Haddad-Boubaker, Sondes
    Ben Aoun, Yusr Saadi
    Triki, Henda
    Guizani, Ikram
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [35] Detection of SARS-CoV-2 Neutralizing Antibodies in Vaccinated Pregnant Women and Neonates by Using a Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader
    Chen, Wei-Chun
    Lin, Yen-Pin
    Cheng, Chao-Min
    Shen, Ching-Fen
    Li, Chang-Wei
    Wang, Yu-Kuo
    Shih, Ting-Ying
    Hong, Chitsung
    Chang, Ting-Chang
    Shen, Ching-Ju
    BIOSENSORS-BASEL, 2022, 12 (10):
  • [36] Simultaneously ultrasensitive and quantitative detection of influenza A virus, SARS-CoV-2, and respiratory syncytial virus via multichannel magnetic SERS-based lateral flow immunoassay
    Liu, Zhenzhen
    Wang, Chongwen
    Zheng, Shuai
    Yang, Xingsheng
    Han, Han
    Dai, Yuwei
    Xiao, Rui
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2023, 47
  • [37] One-pot synthesized Au@Pt nanostars-based lateral flow immunoassay for colorimetric and photothermal dual-mode detection of SARS-CoV-2 nucleocapsid antibody
    Zhu, Jinyue
    Guo, Gengchen
    Liu, Jianting
    Li, Xiang
    Yang, Xianning
    Liu, Min
    Fu, Chunhui
    Zeng, Jingbin
    Li, Jingwen
    ANALYTICA CHIMICA ACTA, 2024, 1292
  • [38] Sensitive and Simultaneous Detection of SARS-CoV-2-Specific IgM/IgG Using Lateral Flow Immunoassay Based on Dual-Mode Quantum Dot Nanobeads
    Wang, Chongwen
    Yang, Xingsheng
    Gu, Bing
    Liu, Haifeng
    Zhou, Zihui
    Shi, Luoluo
    Cheng, Xiaodan
    Wang, Shengqi
    ANALYTICAL CHEMISTRY, 2020, 92 (23) : 15542 - 15549
  • [39] The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device
    Nishimura, Kengo
    Kitazawa, Hiroaki
    Kawahata, Takashi
    Yuhara, Kosuke
    Masuya, Takahiro
    Kuroita, Toshihiro
    Waki, Kentarou
    Koike, Seiichi
    Isobe, Masaharu
    Kurosawa, Nobuyuki
    BMC IMMUNOLOGY, 2023, 24 (01)
  • [40] The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device
    Kengo Nishimura
    Hiroaki Kitazawa
    Takashi Kawahata
    Kosuke Yuhara
    Takahiro Masuya
    Toshihiro Kuroita
    Kentarou Waki
    Seiichi Koike
    Masaharu Isobe
    Nobuyuki Kurosawa
    BMC Immunology, 24